Scientific Report Questions Effectiveness of 'Breakthrough' Alzheimer's Drugs

A new scientific report raises concerns about the actual efficacy of recently marketed Alzheimer's drugs, Leqimbi and Kisunla, questioning their ability to significantly slow the disease.

18 Apr, 13:00 — 18 Apr, 13:00

Post Share

Sources

Showing 1 of 1 sources

marketwatchMostly Factual2h ago

These Alzheimer’s drugs were supposed to revolutionize the way we fight the disease. The reality is more complicated.

A scientific report has raised questions about how much Leqimbi and Kisunla — the “breakthrough” Alzheimer’s drugs that have hit the market in the last few years — really help slow the disease.

By Brett Arends

Read full article →

PERSPECTA

PERSPECTA

Scientific Report Questions Effectiveness of 'Breakthrough' Alzheimer's Drugs

Sources

These Alzheimer’s drugs were supposed to revolutionize the way we fight the disease. The reality is more complicated.

Related Stories

'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video

Climate Advisors Help Gardeners Adapt to Changing Weather Patterns

Can the Giant Magellan Telescope spot habitable worlds? Funding holds the key

PGI to Relocate Neurology and Neurosurgery OPDs to Advanced Neuroscience Centre

PERSPECTA